Hemorrhagic stroke. | Semantic Scholar (2024)

This review synthesized existing literature and first provided an overview of the basic structure and function of NVU, followed by knowledge of how these components remodel in response to ischemic stroke and brain hemorrhage.

Seven metabolites with increasing plasma levels across different stroke risk groups, from LSR to HSR, can be used for early detection and to detect increasing stages of stroke risk more efficiently and are termed “unknown-1” and “ unknown-3”.

A 54-year-old male with a history of type-2 diabetes mellitus who experienced sudden unconsciousness and vomiting, leading to aspiration and subsequent diagnosis of a hemorrhagic stroke, and underwent an immediate decompressive craniotomy revealing a sizable intraparenchymal hematoma.

This study found a causal relationship between genetic susceptibility to PD and the incidence of stroke (especially IS) in the European population; however, there was no causal relation between AD and stroke risk.

A low GNRI is associated with poor functional and survival outcomes in patients with ischemic stroke and in prospective cohort studies, according to the aim of the meta-analysis.

The authors highlight the role of mitochondrial ROS in various forms of brain injury, emphasizing both the collective and unique elements of each form and the current therapeutic landscape and the roles of emerging therapies in treating reactive oxygen species in brain injuries.

The basics of stroke are outlined, including its pathophysiology, factors affecting its development, current treatment therapies, and their limitations, and stimuli-responsive nanotherapeutics used for diagnosing and treating stroke with challenges ahead for the safe use of nanotherAPEutics are discussed.

...

...

Validated baseline predictors of clinical outcome after ICH include the Glasgow Coma Scale score, hematoma volume, presence and amount of intraventricular hemorrhage, infratentorial ICH location, and advanced age.

Animal models demonstrate clot removal can improve the acute and long-term consequences of intraventricular extension from intracerebral hemorrhage by using minimally invasive techniques coupled to recombinant tissue plasminogen activator-mediated clot lysis.

Evidence for a genetic contribution to ICH is focused on, approaches to genetic studies of ICH are delineated, and foundations for their future applications are explored.

Current treatments for NOAC-associated ICH include nonactivated and activated prothrombin complex concentrate, which reverse the anticoagulant effects of the NOACs, but their effects on bleeding and patient outcome are not known.

Patients taking warfarin had a doubling in the rate of intracerebral hemorrhage mortality in a dose-dependent manner, and the data suggest that careful control of the INR, already known to limit the risk of warFarin-related ICH, may also limit its severity.

Symptomatic ICH after IA thrombolysis with r-proUK for acute ischemic stroke occurs early after treatment and has high mortality, and the risk of symptomatic I CH may be increased in patients with a blood glucose >200 mg/dL at stroke onset.

Among young men and women, the major risk factors for primary ICH can be modified, suggesting that this type of stroke may be preventable, and findings for caffeine and menopause warrant further study.

Intracerebral hemorrhage accounts for 10 to 15 percent of all cases of stroke and is associated with the highest mortality rate, with only 38 percent of affected patients surviving the first year.

Data from this systematic review should not alter the current guidelines for the use of rt-PA in acute stroke, but may help develop future strategies aimed at reducing the rate of thrombolysis-associated SICH.

Hemorrhages tended to be in the lobar regions of the brain, and most occurred with an international normalized ratio of ≤3.0, suggesting CAA is an important cause of warfarin-associated lobar ICH in the elderly.

...

...